FRIDAY 6, NOVEMBER
(16:50 – 17:00, GMT -3) OPENING

ROOM “A”

Pulmonary Hypertension

(17:00 – 18:30, GMT -3)
With Unrestricted Grant from:
Chairmen: Roberto Favaloro – Liliana Favaloro – Jorge Cáneva
17:00 – 17:20
Pulmonary Hypertension in Chronic Lung Disease. Joan A. Barberà (Spain).
17:20 – 17:40
Pulmonary Arterial Hypertension: Risk Stratification and Initial Treatment. Nazzareno Galiè (ltaly).
17:40 – 18:00
CTEPH: Pulmonary (Thrombo) Endarterectomy & Other Therapeutic Options. Eckhard Mayer (Germany).
18:00 – 18:30
Panel Discussion.

Structural Heart Disease I: Aortic Disease

(18:30 – 20:00, GMT -3)
With Unrestricted Grant from:
Chairmen: Oscar Mendiz – Horacio Casabé – Roberto Favaloro
18:30 – 18:45
Reducing PPMI Rate after TAVR. Hemal Gada (USA).
18:45 – 19:00
lmproving Coronary Accessibility after TAVR. Gilbert Tang (USA).
19:00 – 19:15
TAVR Durability. Eberhard Grube (Germany).
19:15 – 19:30
TAVR Cost/Effectiveness. David Cohen (USA).
19:30 – 19:45
Update on SAVR and SAVR after TAVR. Faisal Bakaeen (USA).
19:45 – 20:00
Panel Discussion.

ROOM “B”

lschemic Heart Disease

(17:00 – 18:30, GMT -3)
With Unrestricted Grant from:

Chairmen: Oscar Mendiz – Ernesto Duronto – Alejandro Hershson
17:00 – 17:15
Is lnvasive Physiology Evaluation Mandatory for Coronary Revascularization? Ricardo Petraco Da Cunhas (UK).
17:15 – 17:30
What is new for DAPT? Roxana Mehran (USA).
17:30 – 17:45
DAT after PCI in Ptes with AF. Renato Lopes (USA).
17:45 – 18:00
NOAC for Secondary Prevention. John Eikelboom (Canada).
18:00 – 18:15
Complete Revascularization in ACS. Ori Ben-heyuda (USA).
18:15 – 18:30
Panel Discussion.

Hypertension

(18:30 – 20:00, GMT -3)
With Unrestricted Grant from:
Chairmen: Ramiro Sánchez – Agustín Ramírez
18:30 – 18:50
Role of biochemical monitoring of adherence In the management of hypertension. Wanpen Vongpatanasin (USA).
18:50 – 19:10
Pre-Hypertension and Cardiovascular Risk. Role of Sympathetic Nervous System. Stevo Julius (USA).
19:10 – 19:30
Treatment of Hypertension to Prevent Cardiovascular Events. Giuseppe Mancia (ltaly).
19:30 – 19:50
Renal Denervation. Felix Mahfoud (Germany).
19:50 – 20:00
Panel Discussion.

ROOM “A” – ROOM “B”: KEYNOTE LECTURE

(20:00 – 20:15, GMT -3)
CV Outcomes During the COVID Pandemic. Prof. Mamas Mamas (UK).

SATURDAY 7, NOVEMBER

ROOM “A”

Structural Heart Disease II: Mitral Valve Disease

(09:00 – 10:30, GMT -3)
With Unrestricted Grant from:
Chairmen: Oscar Mendiz – Eduardo Guevara – José Abud – Fabián Salmo
09:00 – 09:15
How to Select Ptes with MR for Edge-to-Edge Repair? Anita Asgar (Canada).
09:15 – 09:30
How to Select Different Available Clips. Saibal Kar (USA).
09:30 – 09:45
Long-Term follow-Up after Edge-to-Edge Repair. Federico Asch (USA).
09:45 – 10:00
Percutaneous Mitral Valve Replacement. Hemal Gada (USA).
10:00 – 10:15
MV Minimally Invasive Surgical Repair. Marc Gillonov (USA).
10:15 – 10:30
Panel Discussion.

Structural Heart Disease III: The Right Side

(10:30 – 12:00, GMT -3)
With Unrestricted Grant from:
Chairmen: Oscar Mendiz – Daniel Absi – Germán Henestrosa
10:30 – 10:45
Pulmonic Valve Replacement; What’s New? Ziyad Hijazi (Qatar).
10:45 – 11:00
LAAC; New Evidence and Devices. Horst Sievert (Germany).
11:00 – 11:15
Atrial Septal Flow Regulator for Ptes with HF. Horst Sievert (Germany).
11:15 – 11:30
Percutaneous Tricuspid Repair. Ralph-Stephan von Bardeleben (Germany).
11:30 – 11:45
Panel Discussion.
11:45 – 12:00
Conference Women in Cardiology. Mirvat Alasnag (Saudi Arabia).

ROOM “B”

Arrhythmias

(09:00 – 10:30, GMT -3)
With Unrestricted Grant from:
Chairmen: José Luis González – Néstor Galizio
09:00 – 09:15
AF ablation for Young and Elderly Patients. Carlos Morillo (USA).
09:15 – 09:30
Arrhythmia-Induced Cardiomyopathy. Mario Gonzalez (USA).
09:30 – 09:45
Subcutaneous ICD Indications. Sergio Pinski (USA).
09:45 – 10:00
Ventricular Extrasystole Indication of PVC Ablation in normal heart. Fermin García (USA).
10:00 – 10:30
Panel Discussion.

Diabetes & CardioMetabolism

(10:30 – 12:00, GMT -3)
With Unrestricted Grant from:
Chairmen: Carla Musso – Alejandro Hershson – Gustavo Giunta
10:30 – 10:45
SGLT2i Mechanism and Cardiovascular Impact. Gilberto Castillo (Colombia).
10:45 – 11:00
GLp1 ag: Effects Besides Diabetes.  Fernando Lavalle (Mexico).
11:00 – 11:15
Current Approach for cardio-renal Disease. Jorge Castillo (Colombia).
11:15 – 11:30
Obesity: Pharmacological Approach. Amelio Godoy Matos (Brazil).
11:30 – 12:00
Panel Discussion.

ROOM “A” – ROOM “B”: CLOSING CONFERENCE

(12:00 – 12:45, GMT -3)
Chairmen: Liliana Favaloro – Roberto Favaloro – Oscar Mendiz.
Predicting Progression of Subclinical CVD and Cognitive Dysfunction by Noninvasive Imaging (3D-US, PET, MRI) Stratification. Prof. Valentin Fuster (USA).